GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,785,000 | -12.7% | 250,000 | 0.0% | 0.48% | -31.4% |
| Q2 2020 | $15,783,000 | +23.6% | 250,000 | 0.0% | 0.69% | -20.3% |
| Q1 2020 | $12,773,000 | -35.7% | 250,000 | 0.0% | 0.87% | -22.5% |
| Q4 2019 | $19,873,000 | +63.8% | 250,000 | 0.0% | 1.12% | +27.9% |
| Q3 2019 | $12,130,000 | -7.8% | 250,000 | 0.0% | 0.88% | -22.3% |
| Q2 2019 | $13,150,000 | -0.6% | 250,000 | 0.0% | 1.13% | -26.1% |
| Q1 2019 | $13,233,000 | -53.9% | 250,000 | -64.3% | 1.53% | -56.9% |
| Q4 2018 | $28,735,000 | – | 700,000 | – | 3.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |